Serina Therapeutics logo

Serina Therapeutics

SER | AMEX
Chart Builder DCF Calculator
$1.42
+$0.03 (+2.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.48
+$0.06 (+4.23%)
After-hours: Nov 16, 2026, 7:00 PM ET
+2.16%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
33.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #699/1021 (Top 68%)

Key Statistics

Market Data

Market Cap $36.09M
1D Range
1.31 1.45
52W Range
1.28 4.26

Valuation (TTM)

PE -0.81
PB 2.59
EV/EBITDA -0.79

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $8.00
Loading financial charts...

Profile

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate inten...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Nov 28, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.31
Beat +8.30%
REV
$125K
Beat 0.00%
Next Earnings
Mar 30, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$8.00
Upside
+463.38%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.